Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: KAKALAK who wrote (6076)	5/18/1998 5:27:00 PM
From: OLD JAKE JUSTUS	Respond to of 8902

All is well, Sir! You are a gentleman and a scholar! I hereby welcome you with open arms! It is good to have you posting here on our thread. I hereby take back all the unkind words I have thought and said about you. You probably did not deserve them anyway. Peace and love to you and all the rest of the readers of our thread!

To: KAKALAK who wrote (6076)	5/18/1998 10:40:00 PM
From: KAKALAK	Respond to of 8902

The following is hearsay, albeit from a source I consider to be beyond second guessing. The Yonkers facility is only for administrative and R&D. ADVR has a manufacturing facility on Grand Bahama which will produce ampules of Reticulose for international sales. When US FDA approval is granted, a manufacturing facility within the US will be developed for domestic consumption. Reticulose is closer to approval for topical application than systemic application (Herpes vs. HIV). The compound is not effected by heat. This makes distribution less problematic as it does not require refrigeration en route. An enforceable patent will be granted which in turn will make Reticulose proprietary to ADVR. Thursday's (5/21/98) presentation at the College of Microbiologists' Conference in Atlanta, GA will include a Q&A session. Of significance is the continuing follow up on the original HIV/Reticulose patients. Also, there is further long term data of Reticulose's zero toxicity and zero side effect characteristics. I'll pass along more data as it becomes available. Obviously the above contains speculation, do your own DD and invest accordingly. I have bet the farm on ADVR. This post is a recommendation to buy shares in ADVR. KAKALAK